Technical Analysis for NCYT - Novacyt S.A.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 70.00 | 8.70% | 5.60 |
NCYT closed up 8.7 percent on Friday, April 19, 2024, on 4.92 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Apr 25
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Slingshot Bullish | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Parabolic Rise | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% |
| Alert | Time |
|---|---|
| Up 2 ATRs | about 11 hours ago |
| Up 10% | about 11 hours ago |
| Rose Above Previous Day's High | about 11 hours ago |
| Outside Day | about 11 hours ago |
| Possible Pocket Pivot | about 15 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Novacyt SA is a France-based company that develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The Company develops a secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The Company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of over 10 distributors. The Company’s subsidiaries include Lab21 Ltd and Primer Design Ltd both based in the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Automated Molecular Molecular Biology Infectious Causes Of Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Automated Molecular Molecular Biology Infectious Causes Of Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 86.0 |
| 52 Week Low | 36.15 |
| Average Volume | 82,083 |
| 200-Day Moving Average | 56.39 |
| 50-Day Moving Average | 47.82 |
| 20-Day Moving Average | 50.18 |
| 10-Day Moving Average | 56.07 |
| Average True Range | 4.52 |
| RSI (14) | 85.73 |
| ADX | 35.23 |
| +DI | 39.48 |
| -DI | 4.37 |
| Chandelier Exit (Long, 3 ATRs) | 60.48 |
| Chandelier Exit (Short, 3 ATRs) | 56.56 |
| Upper Bollinger Bands | 65.15 |
| Lower Bollinger Band | 35.20 |
| Percent B (%b) | 1.16 |
| BandWidth | 59.68 |
| MACD Line | 4.52 |
| MACD Signal Line | 2.19 |
| MACD Histogram | 2.3317 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 87.77 | ||||
| Resistance 3 (R3) | 87.14 | 80.59 | 84.81 | ||
| Resistance 2 (R2) | 80.59 | 76.07 | 80.91 | 83.82 | |
| Resistance 1 (R1) | 75.30 | 73.27 | 77.95 | 75.92 | 82.83 |
| Pivot Point | 68.75 | 68.75 | 70.07 | 69.06 | 68.75 |
| Support 1 (S1) | 63.45 | 64.22 | 66.10 | 64.08 | 57.17 |
| Support 2 (S2) | 56.90 | 61.43 | 57.22 | 56.18 | |
| Support 3 (S3) | 51.61 | 56.90 | 55.19 | ||
| Support 4 (S4) | 52.23 |
